Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation
Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation
Recruiting · NCT06050980 · Registry updated 2023-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation | non-small cell lung carcinoma | Recruiting | Phase 1 | 2023-09-22 | NCT06050980 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Haisco Pharmaceutical Group Co., Ltd. | 50 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing | China | 71 |
| Chongqing Cancer Hospital | Chongqing | China | 3 |
| First Affiliated Hospital of Henan University of Science and Technology | Luoyang | China | 2 |
| Fujian Cancer Hospital | Fuzhou | China | 18 |
| Guangxi Medical University Cancer Hospital | Nanning | China | 4 |
| Harbin Medical University Cancer Hospital | Harbin | China | 102 |
| Henan Cancer Hospital | Zhengzhou | China | 76 |
| Hunan Cancer Hospital | Changsha | China | 27 |
| Shandong Cancer Hospital | Jinan | China | 86 |
| Shanghai Pulmonary Hospital | Shanghai | China | 72 |
| Taizhou hospital of Zhejiang Province | Taizhou | China | 1 |
| The First Hospital of China Medical University | Shenyang | China | 12 |